Literature DB >> 35879464

Neurovascular dysfunction in GRN-associated frontotemporal dementia identified by single-nucleus RNA sequencing of human cerebral cortex.

John C van Swieten1, Bart J L Eggen2, Emma Gerrits3, Lucia A A Giannini1, Nieske Brouwer3, Shamiram Melhem1, Danielle Seilhean4,5, Isabelle Le Ber5,6, Alwin Kamermans7, Gijs Kooij7, Helga E de Vries7, Erik W G M Boddeke3,8, Harro Seelaar1.   

Abstract

Frontotemporal dementia (FTD) is the second most prevalent form of early-onset dementia, affecting predominantly frontal and temporal cerebral lobes. Heterozygous mutations in the progranulin gene (GRN) cause autosomal-dominant FTD (FTD-GRN), associated with TDP-43 inclusions, neuronal loss, axonal degeneration and gliosis, but FTD-GRN pathogenesis is largely unresolved. Here we report single-nucleus RNA sequencing of microglia, astrocytes and the neurovasculature from frontal, temporal and occipital cortical tissue from control and FTD-GRN brains. We show that fibroblast and mesenchymal cell numbers were enriched in FTD-GRN, and we identified disease-associated subtypes of astrocytes and endothelial cells. Expression of gene modules associated with blood-brain barrier (BBB) dysfunction was significantly enriched in FTD-GRN endothelial cells. The vasculature supportive function and capillary coverage by pericytes was reduced in FTD-GRN tissue, with increased and hypertrophic vascularization and an enrichment of perivascular T cells. Our results indicate a perturbed BBB and suggest that the neurovascular unit is severely affected in FTD-GRN.
© 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35879464     DOI: 10.1038/s41593-022-01124-3

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   28.771


  82 in total

Review 1.  Neuroinflammation in frontotemporal dementia.

Authors:  Fiona Bright; Eryn L Werry; Carol Dobson-Stone; Olivier Piguet; Lars M Ittner; Glenda M Halliday; John R Hodges; Matthew C Kiernan; Clement T Loy; Michael Kassiou; Jillian J Kril
Journal:  Nat Rev Neurol       Date:  2019-07-19       Impact factor: 42.937

Review 2.  Molecular neuropathology of frontotemporal dementia: insights into disease mechanisms from postmortem studies.

Authors:  Ian R A Mackenzie; Manuela Neumann
Journal:  J Neurochem       Date:  2016-06-15       Impact factor: 5.372

3.  Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21.

Authors:  Marc Cruts; Ilse Gijselinck; Julie van der Zee; Sebastiaan Engelborghs; Hans Wils; Daniel Pirici; Rosa Rademakers; Rik Vandenberghe; Bart Dermaut; Jean-Jacques Martin; Cornelia van Duijn; Karin Peeters; Raf Sciot; Patrick Santens; Tim De Pooter; Maria Mattheijssens; Marleen Van den Broeck; Ivy Cuijt; Krist'l Vennekens; Peter P De Deyn; Samir Kumar-Singh; Christine Van Broeckhoven
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

Review 4.  Progranulin, lysosomal regulation and neurodegenerative disease.

Authors:  Aimee W Kao; Andrew McKay; Param Priya Singh; Anne Brunet; Eric J Huang
Journal:  Nat Rev Neurosci       Date:  2017-04-24       Impact factor: 34.870

5.  Progranulin and granulin-like protein as novel VEGF-independent angiogenic factors derived from human mesothelioma cells.

Authors:  R Eguchi; T Nakano; I Wakabayashi
Journal:  Oncogene       Date:  2016-06-27       Impact factor: 9.867

Review 6.  Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia.

Authors:  John C van Swieten; Peter Heutink
Journal:  Lancet Neurol       Date:  2008-09-02       Impact factor: 44.182

7.  Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia.

Authors:  Carolin Heller; Martha S Foiani; Katrina Moore; Rhian Convery; Martina Bocchetta; Mollie Neason; David M Cash; David Thomas; Caroline V Greaves; Ione Oc Woollacott; Rachelle Shafei; John C Van Swieten; Fermin Moreno; Raquel Sanchez-Valle; Barbara Borroni; Robert Laforce; Mario Masellis; Maria Carmela Tartaglia; Caroline Graff; Daniela Galimberti; James B Rowe; Elizabeth Finger; Matthis Synofzik; Rik Vandenberghe; Alexandre de Mendonca; Fabrizio Tagliavini; Isabel Santana; Simon Ducharme; Christopher R Butler; Alex Gerhard; Johannes Levin; Adrian Danek; Giovanni Frisoni; Sandro Sorbi; Markus Otto; Amanda J Heslegrave; Henrik Zetterberg; Jonathan D Rohrer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-01-14       Impact factor: 10.154

8.  Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17.

Authors:  Matt Baker; Ian R Mackenzie; Stuart M Pickering-Brown; Jennifer Gass; Rosa Rademakers; Caroline Lindholm; Julie Snowden; Jennifer Adamson; A Dessa Sadovnick; Sara Rollinson; Ashley Cannon; Emily Dwosh; David Neary; Stacey Melquist; Anna Richardson; Dennis Dickson; Zdenek Berger; Jason Eriksen; Todd Robinson; Cynthia Zehr; Chad A Dickey; Richard Crook; Eileen McGowan; David Mann; Bradley Boeve; Howard Feldman; Mike Hutton
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

Review 9.  Imaging and fluid biomarkers in frontotemporal dementia.

Authors:  Lieke H Meeter; Laura Donker Kaat; Jonathan D Rohrer; John C van Swieten
Journal:  Nat Rev Neurol       Date:  2017-06-16       Impact factor: 42.937

Review 10.  The clinical spectrum of sporadic and familial forms of frontotemporal dementia.

Authors:  Ione O C Woollacott; Jonathan D Rohrer
Journal:  J Neurochem       Date:  2016-06-15       Impact factor: 5.372

View more
  1 in total

1.  Surprise neurovascular dysfunction in frontotemporal dementia.

Authors:  Ian Fyfe
Journal:  Nat Rev Neurol       Date:  2022-09       Impact factor: 44.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.